Preventive effect of pregabalin on oxaliplatin-related neurotoxicity for patients with advanced/recurrent colorectal cancer: a prospective phase 2 study
Ontology highlight
ABSTRACT: Interventions: Pregabalin is administered during FOLFOX or XELOX therapy. Initial dose:75mg twice daily(150mg/day),increased to 300 - 600mg/day if there was persistent paresthesia or functional impariment(Grade2 or more).
Primary outcome(s): Neurotoxicity frequency of accumulation dose 500mg/m2 of L-OHP (Grade2 or more)
Study Design: Single arm Non-randomized
DISEASE(S): Colorectal Cancer
PROVIDER: 2624861 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA